A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans

Background. Many human immunodeficiency virus (HIV)-infected patients remain on nevirapine-based antiretroviral therapy (ART) despite safety and efficacy concerns. Switching to a rilpivirine-based regimen is an alternative, but there is little experience with rilpivirine in sub-Saharan Africa where...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Sean E., Grant, Philip M., Uwinkindi, Francois, Talbot, Annie, Seruyange, Eric, Slamowitz, Deborah, Mugeni, Adeline, Remera, Eric, Niyonsenga, Simon Pierre, Nyirimigabo, Josbert, Uwizihiwe, Jean Paul, Dongier, Pierre, Muhayimpundu, Ribakare, Mazarati, Jean-Baptiste, Zolopa, Andrew, Nsanzimana, Sabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047400/
https://www.ncbi.nlm.nih.gov/pubmed/27704000
http://dx.doi.org/10.1093/ofid/ofw141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047400/
https://www.ncbi.nlm.nih.gov/pubmed/27704000
http://dx.doi.org/10.1093/ofid/ofw141

Ejemplares similares